Evidence map›Paper›PMID 26287315›Full record

ArticleKidney international2015

Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury.

Ryan M Whitaker, L Jay Stallons, Joshua E Kneff, Joseph L Alge, Jennifer L Harmon, Jennifer J Rahn, John M Arthur, Craig C Beeson, Sherine L Chan, Rick G Schnellmann

Registry-linked trialAbstract read
In one paragraph

Article in Kidney international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05458063 (The Effectiveness of the Urine Mitochondrial Deoxyribonucleic Acid and, Serum Beta 2 Microglobulin as a Biomarker of Renal Function Impairment in Critically Ill Surgical Patients), which is not on this map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05458063 completednot on this mapstarted 2022, after this paper: background citation

The Effectiveness of the Urine Mitochondrial Deoxyribonucleic Acid and, Serum Beta 2 Microglobulin as a Biomarker of Renal Function Impairment in Critically Ill Surgical Patients

TypeobservationalSponsorWonju Severance Christian HospitalRan2022 to 2024Enrolled113ConditionsSurgery-Complications, Acute Kidney Injury, Critical Illness
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 104 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ryan M WhitakerDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
L Jay StallonsDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Joshua E KneffDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Joseph L AlgeDivision of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Jennifer L HarmonDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Jennifer J RahnDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
John M ArthurDivision of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Craig C BeesonDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Sherine L ChanDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Rick G SchnellmannDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Medical University of South Carolina · US

Funding

TRAINING PROGRAM FOR MEDICAL SCIENTISTST32GM008716 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DEMORE, NANCY · 1999 to 2024
$9.3M
Mitochondrial Biogenesis Promotes Recovery From Oxidant InjuryR01GM084147 · NIGMS · UNIVERSITY OF ARIZONA · PI SCHNELLMANN, RICK G · 2008 to 2016
$2.4M
Orbitrap Mass SpectrometerS10OD010731 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2012 to 2012
$600k
Stimulation of Mitochondrial Biogenesis with PDE3 InhibitorsF30DK096964 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WHITAKER, RYAN M. · 2012 to 2015
$171k
NIDDK NIH HHS F30 DK096964NIGMS NIH HHS R01 GM084147NIGMS NIH HHS T32 GM008716NIH HHS S10 OD010731
6 · The paper itself

Abstract

Recent studies show the importance of mitochondrial dysfunction in the initiation and progression of acute kidney injury (AKI). However, no biomarkers exist linking renal injury to mitochondrial function and integrity. To this end, we evaluated urinary mitochondrial DNA (UmtDNA) as a biomarker of renal injury and function in humans with AKI following cardiac surgery. mtDNA was isolated from the urine of patients following cardiac surgery and quantified by quantitative PCR. Patients were stratified into no AKI, stable AKI, and progressive AKI groups based on Acute Kidney Injury Network (AKIN) staging. UmtDNA was elevated in progressive AKI patients and was associated with progression of patients with AKI at collection to higher AKIN stages. To evaluate the relationship of UmtDNA to measures of renal mitochondrial integrity in AKI, mice were subjected to sham surgery or varying degrees of ischemia followed by 24 h of reperfusion. UmtDNA increased in mice after 10-15 min of ischemia and positively correlated with ischemia time. Furthermore, UmtDNA was predictive of AKI in the mouse model. Finally, UmtDNA levels were negatively correlated with renal cortical mtDNA and mitochondrial gene expression. These translational studies demonstrate that UmtDNA is associated with recovery from AKI following cardiac surgery by serving as an indicator of mitochondrial integrity. Thus UmtDNA may serve as valuable biomarker for the development of mitochondrial-targeted therapies in AKI.

Identifiers

PMID26287315
PMCPMC4675682
OpenAlexW1880886285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.